By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ)

SHZ Currency in CNY
¥6.52
+¥0.04
+0.62%
Last Update: 8 Jul 2025, 07:04
¥3.28B
Market Cap
22.77
P/E Ratio (TTM)
Forward Dividend Yield
¥4.90 - ¥6.83
52 Week Range

002412.SZ Stock Price Chart

Explore Hunan Hansen Pharmaceutical Co., Ltd. interactive price chart. Choose custom timeframes to analyze 002412.SZ price movements and trends.

There is nothing to show.

002412.SZ Company Profile

Discover essential business fundamentals and corporate details for Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

25 May 2010

Employees

1.54K

CEO

Zhengqing Liu

Description

Hunan Hansen Pharmaceutical Co., Ltd. produces and sells Chinese and chemical medicine preparations in China and internationally. It provides medicines in injection, oral liquid, tablet, capsule, granule, syrup, decoction, tincture, and pill forms. The company is based in Yiyang, China.

002412.SZ Financial Timeline

Browse a chronological timeline of Hunan Hansen Pharmaceutical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 21 May 2025

EPS came in at ¥0.18, while revenue for the quarter reached ¥310.49M.

Earnings released on 31 Mar 2025

EPS came in at ¥0.02, while revenue for the quarter reached ¥269.29M.

Earnings released on 29 Sept 2024

EPS came in at ¥0.06, while revenue for the quarter reached ¥213.54M.

Earnings released on 29 Jun 2024

EPS came in at ¥0.08, while revenue for the quarter reached ¥222.04M.

Earnings released on 21 May 2024

EPS came in at ¥0.19, while revenue for the quarter reached ¥266.14M.

Earnings released on 31 Mar 2024

EPS came in at ¥0.12, while revenue for the quarter reached ¥248.83M.

Earnings released on 30 Sept 2023

EPS came in at ¥0.04, while revenue for the quarter reached ¥212.47M.

Earnings released on 30 Jun 2023

EPS came in at ¥0.07, while revenue for the quarter reached ¥221.49M.

Dividend declared on 20 Jun 2023

A dividend of ¥0.30 per share was announced, adjusted to ¥0.30. The dividend was paid on 20 Jun 2023.

Earnings released on 31 Mar 2023

EPS came in at ¥0.11, while revenue for the quarter reached ¥250.18M.

Earnings released on 1 Jan 2023

EPS came in at ¥0.07, while revenue for the quarter reached ¥234.91M.

Earnings released on 30 Sept 2022

EPS came in at ¥0.10, while revenue for the quarter reached ¥218.47M.

Earnings released on 30 Jun 2022

EPS came in at ¥0.05, while revenue for the quarter reached ¥213.83M.

Earnings released on 31 Mar 2022

EPS came in at ¥0.10, while revenue for the quarter reached ¥248.85M.

Earnings released on 31 Dec 2021

EPS came in at ¥0.04, while revenue for the quarter reached ¥231.92M.

Earnings released on 30 Sept 2021

EPS came in at ¥0.09, while revenue for the quarter reached ¥216.83M.

Earnings released on 30 Jun 2021

EPS came in at ¥0.05, while revenue for the quarter reached ¥207.70M.

Earnings released on 29 Apr 2021

EPS came in at ¥0.04, while revenue for the quarter reached ¥219.34M.

Earnings released on 31 Mar 2021

EPS came in at ¥0.09, while revenue for the quarter reached ¥235.39M.

Earnings released on 26 Oct 2020

EPS came in at ¥0.06, while revenue for the quarter reached ¥210.17M.

Earnings released on 21 Aug 2020

EPS came in at ¥0.03, while revenue for the quarter reached ¥137.38M.

002412.SZ Stock Performance

Access detailed 002412.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
002412.SZ
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
002412.SZ
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More